The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia-Reference-Cited by-同舟云学术

The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia

Published:2013-06 Issue:6 Volume:80 Page:827-832
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Ewing Samuel G.,Winter Christine

Publisher

Elsevier BV

Subject

General Medicine

Reference88 articles.

1. Murthy RS, Bertolote JM, Epping-Jordan J, Funk M, Prentice T, Saraceno B et al. The world health report: 2001: mental health: new understanding, new hope. Tech. Rep.; World Health Organisation; 2001.

2. The relationship between brain structure and neurocognition in schizophrenia: a selective review;Antonova;Schizophr Res,2004

3. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes;Snitz;Schizophr Bull,2006

4. Another view of therapy for cognition in schizophrenia;Carpenter;Biol Psychiatry,2002

5. Dopamine partial agonists: a new class of antipsychotic;Lieberman;CNS Drugs,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms;Schizophrenia;2024-07-23

2. The complexity of ventral CA1 and its multiple functionalities;Genes, Brain and Behavior;2022-07-11

3. Effect of dimethyl fumarate on the changes in the medial prefrontal cortex structure and behavior in the poly(I:C)-induced maternal immune activation model of schizophrenia in the male mice;Behavioural Brain Research;2022-01

4. Prenatal Zinc Supplementation Ameliorates Hippocampal Astrocytes Activation and Inflammatory Cytokines Expression Induced by Lipopolysaccharide in a Rat Model of Maternal Immune Activation;Basic and Clinical Neuroscience Journal;2021-07-19

5. Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval;Frontiers in Psychiatry;2021-03-24